Due the voluminous number of all research articles, please wait for a moment.

Guanfacine`s mechanism of action in treating prefrontal cortical disorders: Successful translation across species

date_range 2020
person
Author Arnsten A.F.T.
description
Abstract The selective norepinephrine (NE) α2A-adrenoceptor (α2A-AR) agonist, guanfacine (Intuniv™), is FDA-approved for treating Attention Deficit Hyperactivity Disorder (ADHD) based on research in animals, a translational success story. Guanfacine is also widely used off-label in additional mental disorders that involve impaired functioning of the prefrontal cortex (PFC), including stress-related disorders such as substance abuse, schizotypic cognitive deficits, and traumatic brain injury. The PFC subserves high order cognitive and executive functions including working memory, abstract reasoning, insight and judgment, and top-down control of attention, action and emotion. These abilities arise from PFC microcircuits with extensive recurrent excitation through NMDAR synapses. There is powerful modulation of these synapses, where cAMP-PKA opening of nearby potassium (K+) channels can rapidly and dynamically alter synaptic strength to coordinate arousal state with cognitive state, e.g. to take PFC “offline” during uncontrollable stress. A variety of evidence shows that guanfacine acts within the PFC via post-synaptic α2A-AR on dendritic spines to inhibit cAMP-PKA-K+ channel signaling, thus strengthening network connectivity, enhancing PFC neuronal firing, and improving PFC cognitive functions. Although guanfacine`s beneficial effects are present in rodent, they are especially evident in primates, where the PFC greatly expands and differentiates. In addition to therapeutic actions in PFC, stress-related disorders may also benefit from additional α2-AR actions, such as weakening plasticity in the amygdala, reducing NE release, and anti-inflammatory actions by deactivating microglia. Altogether, these NE α2-AR actions optimize top-down control by PFC networks, which may explain guanfacine`s benefits in a variety of mental disorders. © 2020 The Author(s)
article
DOI 10.1016/j.nlm.2020.107327
language
Journal Neurobiology of Learning and Memory
description
Source Scopus

Submit your feedback

CARI! has performed crawling, tagging, and other data processing to produce this page. If you find an error or have feedback for this page, please fill out the form below. Thank You.
How to correct
  • Name and Email are required!
  • One of the location fields (prov, district, or sub-district) must be filled in
  • Fields other than those mentioned above are optional